SP1 and early-onset autosomal dominant Alzheimer disease: A study has suggested that the elevation of SP1 levels could trigger cell death in neurodegenerative disorders, including Alzheimer’s disease [16], making it an interesting candidate for therapeutic intervention of neurodegenerative disorders.